OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Miranda Orr

2 Projects | 1 Researchers | $3,589,379 Invested

2022

Wake Forest University Health Sciences

Miranda Orr, PhD

Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery: Senescence Biomarker Discovery

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Tau
  • Status: Active

2020

Wake Forest University Health Sciences

Miranda Orr, PhD

Phase II Clinical Trial to Evaluate the Safety and Feasibily of Senolytic Therapy in Alzheimer's Disease

  • Funding Amount: $3,439,379
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Tau
  • Status: Active